Kenya to Begin Manufacturing Covid-19 Vaccines to Ensure Supply
This article is for subscribers only.
Kenya is establishing a fill-and-finish facility for Covid-19 vaccines ahead of setting up a full-scale manufacturing plant to guarantee supply.
“We aim to start local production during the first quarter of 2022 and have a fully fledged human vaccine manufacturing capability by 2024,” according to the National Covid-19 Vaccine Deployment Plan published by the Ministry of Health.